I am the CEO and founder of Neuronoff, Inc., a company that develops class II and III medical devices to restore and improve organ function using minimally-invasive neuromodulation. I have more than seven years of experience in leading and growing a startup that creates novel solutions for various health conditions, such as dry eye syndrome, urinary incontinence, and chronic pain.
As a neuromodulation expert with a PhD in Neural Engineering and a Dipl.-Ing. in Electrical Engineering, I have a strong research background and a proven track record of designing and executing clinical and pre-clinical studies, obtaining FDA and IRB clearance, and generating patent applications. I have 59 granted patents and 136 out of 194 patent applications as the lead inventor, covering various aspects of neural stimulation and nerve block. I have also co-authored 10+ publications and received multiple honors and awards, such as the Fulbright Fellowship and the Doctoral Excellence Award for Biomedical Engineering.
My mission is to use neural pathways to increase or decrease organ activity with new devices that are safe, effective, and convenient for patients and clinicians. I have successfully translated pre-clinical results into clinical impact, demonstrated the value and mechanisms of action of our products, and defined new clinical labels that doubled the market value. I have also trained and collaborated with clinicians and their staff on novel neuromodulation devices and data acquisition.
I am passionate about entrepreneurship, innovation, and leadership, and I value principles, data, and collaboration over dogma. I have experience in working with both startups (Neuronoff, Oculeve) and big corporations (Allergan, Boston Scientific), and I have learned to balance agility, creativity, and rigor in developing and delivering cutting-edge medical devices that improve the quality of life of millions of people.
I am the CEO and founder of Neuronoff, Inc., a company that develops class II and III medical devices to restore and improve organ function using minimally-invasive neuromodulation. I have more than seven years of experience in leading and growing a startup that creates novel solutions for various health conditions, such as dry eye syndrome, urinary incontinence, and chronic pain.
As a neuromodulation expert with a PhD in Neural Engineering and a Dipl.-Ing. in Electrical Engineering, I have a strong research background and a proven track record of designing and executing clinical and pre-clinical studies, obtaining FDA and IRB clearance, and generating patent applications. I have 59 granted patents and 136 out of 194 patent applications as the lead inventor, covering various aspects of neural stimulation and nerve block. I have also co-authored 10+ publications and received multiple honors and awards, such as the Fulbright Fellowship and the Doctoral Excellence Award for Biomedical Engineering.
My mission is to use neural pathways to increase or decrease organ activity with new devices that are safe, effective, and convenient for patients and clinicians. I have successfully translated pre-clinical results into clinical impact, demonstrated the value and mechanisms of action of our products, and defined new clinical labels that doubled the market value. I have also trained and collaborated with clinicians and their staff on novel neuromodulation devices and data acquisition.
I am passionate about entrepreneurship, innovation, and leadership, and I value principles, data, and collaboration over dogma. I have experience in working with both startups (Neuronoff, Oculeve) and big corporations (Allergan, Boston Scientific), and I have learned to balance agility, creativity, and rigor in developing and delivering cutting-edge medical devices that improve the quality of life of millions of people.
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2025 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy